Advanced search
Publication Cover
Human Vaccines & Immunotherapeutics Volume 17, 2021 - Issue 3
Submit an article Journal homepage
2,508
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Immunogenicity, safety, and reactogenicity of combined reduced-antigen-content diphtheria-tetanus-acellular pertussis vaccine administered as a booster vaccine dose in healthy Russian participants: a phase III, open-label study

Asmik Asatryana Hospital Stomamedservice, Gatchina, Russian FederationView further author information
,
Nadia Meyerb GSK, Wavre, BelgiumView further author information
,
Michael Scherbakovc GSK, Moscow, RussiaORCID Iconhttps://orcid.org/0000-0002-9189-4729View further author information
ORCID Icon,
Victor Romanenkod Children’s City Hospital No11, Ekaterinburg, Russian FederationView further author information
,
Irina Osipovae Ooo “Asko-med-plus”, Barnaul, Russian FederationView further author information
,
Anna Galustyanf Medical Technologies Ltd, St. Petersburg, Russian Federation;g Federal State Budgetary Educational Institution of Higher Education, St. Petersburg State Pediatric Medical University of the Ministry of Healthcare of the Russian Federation, St. Petersburg, Russian FederationView further author information
,
Olga Shamshevah Pirogov Russian National Research Medical University, Moscow, Russian FederationView further author information
,
Tatiana Latyshevai NRC Institute of Immunology FMBA, Moscow, RussiaView further author information
,
Tatyana Myasnikovai NRC Institute of Immunology FMBA, Moscow, RussiaView further author information
,
Nathalie Baudsonj GSK Vaccines, Rixensart, BelgiumView further author information
,
Monique Dodetj GSK Vaccines, Rixensart, BelgiumView further author information
,
Stebin Xavierb GSK, Wavre, BelgiumView further author information
,
Lauriane Harringtonb GSK, Wavre, BelgiumView further author information
,
Anastasia Kuznetsovab GSK, Wavre, BelgiumView further author information
,
Laura Camporab GSK, Wavre, BelgiumView further author information
&
Peter Van den Steenb GSK, Wavre, BelgiumCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-7931-1781View further author information
ORCID Icon show all
Pages 723-730 | Received 16 Mar 2020, Accepted 12 Jul 2020, Published online: 26 Aug 2020

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Hitt J Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Anand Kawade, Mandyam Ravi, Jitendra Oswal, Saji James, N. Mahantashetti, Renuka Munshi, Apurba Ghosh, Venkateshwar Rao, Sundaram Balsubramaniam, P. Varughese, A. Somshekhar, Amy Sarah Ginsburg, Harish Rao, Manish Gautam, Sunil Gairola & Umesh Shaligram. (2023) Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India. Expert Review of Vaccines 22:1, pages 278-287.
Read now

Articles from other publishers (3)

Yan Xu, Haiping Chen, Binbing Wang, Xiaoping Zhu, Linyun Luo, Shengyi Wang, Yanhui Xiao, Hui Wang, Rui Ma, Shaoxiang Liu, Long Yan, Xiuling Li, Dandan Chen, Ying Su, Yu chai, Jun Fu, Xiaoying Mao, Jie Cao, Pufei Sun, Fenyang Tang, Xiang Sun, Zhiguo Wang & Xiaoming Yang. (2023) Immunogenicity and safety of concomitant administration of the sabin-strain-based inactivated poliovirus vaccine, the diphtheria-tetanus-acellular pertussis vaccine, and measles-mumps-rubella vaccine to healthy infants aged 18 months in China. International Journal of Infectious Diseases 137, pages 9-15.
Crossref
Inci Aydin, Marcus May, Fabio Pisano, Nontsikelelo Mpofu-Maetzig, Leander Grode, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Hitt Sharma, Harish Rao, Manish Gautam, Sunil Gairola & Umesh Shaligram. (2023) Safety and immunogenicity of SIIPL Tdap, a new tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine, in healthy subjects 4–65 years of age: A Phase II/III randomized, observer-blinded, active controlled, multicenter clinical study in Germany. Vaccine 41:46, pages 6810-6819.
Crossref
Kimberly N. Garces, Alexandra N. Cocores, Peter J. Goadsby & Teshamae S. Monteith. (2022) Headache After Vaccination: An Update on Recent Clinical Trials and Real-World Reporting. Current Pain and Headache Reports 26:12, pages 895-918.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.